Alzheimer's drug from Eli Lilly wins backing of FDA committee

An advisory committee to the Food and Drug Administration found the drug was safe and effective at slowing the progression of the disease, setting the stage for the agency to approve it.

Related Keywords

United States ,Americans ,William Blair ,Melissa Veenhuizen ,Reisa Sperling ,Eli Lilly ,Mark Mintun ,Howard Fillit ,Judy Butler ,David Risinger ,Alzheimer Research ,Drug Administration On ,Georgetown University Medical Center ,Alzheimer Drug Discovery Foundation ,Drug Administration ,Sarah Dean ,Wall Street ,Leerink Partners ,Drug Discovery Foundation ,